Atrial Fibrillation Clinical Trials in Shanxi, Shanxi
2 recruitingShanxi, Shanxi, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Registry of Multicenter Brain-Heart Comorbidity in China
Heart FailureAtrial FibrillationCardiac Arrest+10 more
Beijing Tiantan Hospital100,000 enrolled14 locationsNCT05961748